Abstract
In 1987, synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome was proposed as an umbrella term for a group of diseases with similar musculoskeletal manifestations, in particular hyperostosis of anterior chest wall, synovitis, and multifocal aseptic osteomyelitis, observed in association with dermatologic conditions such as palmoplantar pustulosis, severe acne, and hidradenitis suppurativa. Despite recent advances in our understanding of the epidemiologic, pathophysiologic, and immunogenetic mechanisms involved in SAPHO syndrome, etiopathogenesis remains poorly understood. Propionibacterium acnes, the microorganism associated with acne, has been recovered on bone biopsy in some patients, but the possible pathogenetic role of an infectious agent in a genetically predisposed individual, resulting in exaggerated inflammatory response as “reactive osteitis,“ is a largely unproven hypothesis. The newly available whole-body MRI will assist early diagnosis by detecting multifocal osteitis lesions, some of them asymptomatic, in axial (anterior chest wall, spine, and jaws) and nonaxial sites. Moreover, outcomes are vastly improved by treatment with bisphosphonates and tumor necrosis factor-α antagonists.
Similar content being viewed by others
References and Recommended Reading
Chamot AM, Benhamou CL, Kahn MF, et al.: Acne-pustulosis-hyperostosis-osteitis syndrome: results of a national survey-85 cases [in French]. Rev Rhum Mal Osteoartic 1987, 54:187–196.
Benhamou CL, Chamot AM, Kahn MF: Synovitis-acnepustulosis hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies? Clin Exp Rheumatol 1988, 6:109–112.
Kahn MF, Khan MA: The SAPHO syndrome. Baillieres Clin Rheumatol 1994, 8:333–362.
Bjorksten B, Gustavson KH, Eriksson B, et al.: Chronic recurrent multifocal osteomyelitis and pustulosis palmoplantaris. J Pediatr 1978, 93:227–231.
Colina M, Govoni M, Orzincolo C, Trotta F: Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 subjects. Arthritis Rheum 2009, 61:813–821.
Takigawa T, Tanaka M, Nakanishi K, et al.: SAPHO syndrome associated spondylitis. Eur Spine J 2008, 17:1391–1397.
Hayem G, Bouchaud-Chabot A, Benali K, et al.: SAPHO syndrome: a long-term follow-up study of 120 cases. Semin Arthritis Rheum 1999, 29:159–171.
Govoni M, Colina M, Massara A, Trotta F: SAPHO syndrome and infections. Autoimmun Rev 2009, 8:256–259.
Colina M, Lo Monaco A, Khodeir M, Trotta F: Propionibacterium acnes and SAPHO syndrome: a case report and literature review. Clin Exp Rheumatol 2007, 25:457–460.
Delyle LG, Vittecoq O, Bourdel A, et al.: Chronic destructive oligoarthritis associated with Propionibacterium acnes in a female patient with acne vulgaris: septic-reactive arthritis? Arthritis Rheum 2000, 43:2843–2847.
Kotilainen P, Merilahti-Palo R, Lehtonen OP, et al.: Propionibacterium acnes isolated from sternal osteitis in a patient with SAPHO syndrome. J Rheumatol 1996, 23:1302–1304.
Queiro R, Moreno P, Sarasqueta C, et al.: Synovitis-acnepustulosis-hyperostosis-osteitis syndrome and psoriatic arthritis exhibit a different immunogenetic profile. Clin Exp Rheumatol 2008, 26:125–128.
Ferguson PJ, Bing X, Vasef MA, et al.: A missense mutation in pstpip2 is associated with the murine autoinflammatory disorder chronic multifocal osteomyelitis. Bone 2006, 38:41–47.
Golla A, Jansson A, Ramser J, et al.: Chronic recurrent multifocal osteomyelitis (CRMO): evidence for a susceptibility gene located on chromosome 18q21.3–18q22. Eur J Hum Genet 2002, 10:217–221.
Hayem G: Valuable lessons from SAPHO syndrome. Joint Bone Spine 2007, 74:123–126.
Hurtado-Nedelec M, Chollet-Martin S, Nicaise-Roland P, et al.: Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. Rheumatology (Oxford) 2008, 47:1160–1167.
Ferguson PJ, Lokuta MA, El-Shanti HI, et al.: Neutrophil dysfunction in a family with a SAPHO syndrome-like phenotype. Arthritis Rheum 2008, 58:3264–3269.
Kahn MF, Bouvier M, Palazzo E, et al.: Sternoclavicular pustulotic osteitis (SAPHO): 20-year interval between skin and bone lesions. J Rheumatol 1991, 18:1104–1108.
Earwaker JW, Cotten A: SAPHO: syndrome or concept? Imaging findings. Skeletal Radiol 2003, 32:311–327.
Cabay JE, Marcelis S, Dondelinger RF: Inflammatory spondylodiskitis as a unique radiological manifestation of the SAPHO syndrome [in French]. J Radiol 1998, 79:337–340.
Boutin RD, Resnick D: The SAPHO syndrome: an evolving concept for unifying several idiopathic disorders of bone and skin. AJR Am J Roentgenol 1988, 170:585–591.
Van Doornum S, Barraclough D, McColl G, Wicks I: SAPHO: rare or just not recognized? Semin Arthritis Rheum 2000, 30:70–77.
Karadag-Saygi E, Gunduz OH, Gumrukcu G, Akyuz G: SAPHO syndrome: misdiagnosed and operated. Acta Reumatol Port 2008, 33:460–463.
Freyschmidt J, Sternberg A: The bull’s head sign: scintigraphy pattern of sternoclavicular hyperostosis and pustulotic arthrosclerosis. Eur Radiol 1998, 8:807–812.
Laredo JD, Vuillemin-Bodaghi V, Boutry N, et al.: SAPHO syndrome: MR appearance of vertebral involvement. Radiology 2007, 242:825–831.
Romanus R, Yden S: Destructive and ossifying spondylitic changes in rheumatoid ankylosing spondylitis (pelvospondylitis ossificans). Acta Orthop Scand 1952, 22:88–99.
Jevtic V, Kos-Golja M, Rozman B, McCall I: Marginal erosive discovertebral “Romanus” lesions in ankylosing spondylitis demonstrated by contrast enhanced Gd-DTPA magnetic resonance imaging. Skeletal Radiol 2000, 29:27–33.
Weber U, Hodler J, Jurik AG, et al.: Assessment of active spinal inflammatory changes in patients with axial spondyloarthritis: validation of whole body MRI against conventional MRI. Ann Rheum Dis 2009, May 7 (Epub ahead of print).
Weber U, Pfirrmann CWA, Khan MA: Ankylosing spondylitis: update on imaging and therapy. Intl J Adv Rheumatol 2007, 5:2–7.
Olivieri I, Padula A, Palazzi C: Pharmacological management of SAPHO syndrome. Expert Opin Investig Drugs 2006, 15:1229–1233.
Kalke S, Perera SD, Patel ND, et al.: The sternoclavicular syndrome: experience from a district general hospital and results of a national postal survey. Rheumatology (Oxford) 2001, 40:170–177.
Pennanen N, Lapinjoki S, Urtti A, Monkkonen J: Effect of liposomal and free bisphosphonates on the IL-1a, IL-6, and TNFα secretion from RAW264 cells in vitro. Pharm Res 1995, 12:916–22.
Maksymowych WP: Bisphosphonates for arthritis—a confusing rationale. J Rheum 2003, 30:430–434.
Colina M, La Corte R, Trotta F: Sustained remission of SAPHO syndrome with pamidronate: a follow-up of fourteen cases and a review of the literature. Clin Exp Rheumatol 2009, 27:112–125.
Amital H, Applbaum YH, Aamar S, et al.: SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. Rheumatology (Oxford) 2004, 43:658–661.
Marshall H, Bromilow J, Thomas AL, Arden NK: Pamidronate: a novel treatment for the SAPHO syndrome? Rheumatology 2002, 41:231–233.
Guignard S, Job-Deslandre C, Sayag-Boukris V, Kahan A: Pamidronate treatment in SAPHO syndrome. Joint Bone Spine 2002, 69:392–396.
Courtney PA, Hosking DJ, Fairbairn KJ, Deighton CM: Treatment of SAPHO with pamidronate. Rheumatology 2002, 41:1196–1198.
Kerrison C, Davidson JE, Cleary AG, Beresford MW: Pamidronate in the treatment of childhood SAPHO syndrome. Rheumatology 2004, 43:1246–1251.
Kopterides P, Pikazis D, Koufos C: Successful treatment of SAPHO syndrome with zoledronic acid. Arthritis Rheum 2004, 50:2970–2973.
Just A, Adams S, Brinkmeier T, et al.: Successful treatment of primary chronic osteomyelitis in SAPHO syndrome with bisphosphonates [in German]. J Dtsch Dermatol Ges 2008, 6:657–660.
Wagner AD, Andresen J, Jendro MC, et al.: Sustained response to tumor necrosis factor a-blocking agents in two patients with SAPHO syndrome. Arthritis Rheum 2002, 46:1965–1968.
Olivieri I, Padula A, Ciancio G, et al.: Successful treatment of SAPHO syndrome with infliximab: report of two cases. Ann Rheum Dis 2002, 61:375–376.
Iqbal M, Kolodney MS: Acne fulminans with synovitisacne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab. J Am Acad Dermatol 2005, 52:S118–S120.
Deutschmann A, Mache CJ, Bodo K, et al.: Successful treatment of chronic recurrent multifocal osteomyelitis with tumor necrosis factor-a blockage. Pediatrics 2005, 116:1231–1233.
Massara A, Cavazzini PL, Trotta F: In SAPHO syndrome anti-TNF-a therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations. Rheumatology 2006, 45:730–733.
Schilling F, Wagner AD: Azithromycin: an anti-inflammatory effect in chronic recurrent multifocal osteomyelitis? A preliminary report [in German]. Z Rheumatol 2000, 59:352–353.
Ballara SC, Siraj QH, Maini RN, Venables PJ: Sustained response to doxycycline therapy in two patients with SAPHO syndrome. Arthritis Rheum 1999, 42:819–821.
Rozin AP, Nahir AM: Is SAPHO syndrome a target for antibiotic therapy? Clin Rheumatol 2007, 26:817–820.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Magrey, M., Khan, M.A. New insights into synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome. Curr Rheumatol Rep 11, 329–333 (2009). https://doi.org/10.1007/s11926-009-0047-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11926-009-0047-8